Arkolith/Insider Trading/AVLN/Form 4

Novo Holdings A/S

10% OwnerAvalyn Pharma Inc. (AVLN) · full profile →Form 4 · filed May 5, 2026
Net Buying
Open-Market Buys
$10.0M
Open-Market Sells
$0
Net Open-Market Flow
$10.0M
Transactions
7
2 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 1, 2026Conversion(C)3.3M——3.3M
May 1, 2026Buy(P)556K$18.00$10.0M3.9M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 1, 2026Conversion(C)18.0M—$00
May 1, 2026Conversion(C)2.0M—$00
May 1, 2026Conversion(C)25.9M—$00
May 1, 2026Conversion(C)5.6M—$00
May 1, 2026Conversion(C)12.6M—$00

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001388325-26-000021) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML